Evidence map›Paper›PMID 42889155›Full record

ArticleFrontiers in immunology2026

Broad systemic T cell immunity to

Laura E Carreto-Binaghi, Jayaum S Booth, Rezwanul Wahid, Rosangela Salerno-Goncalves, Franklin R Toapanta, Marcelo B Sztein

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura E Carreto-BinaghiCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Jayaum S BoothCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Rezwanul WahidCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Rosangela Salerno-GoncalvesCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Franklin R ToapantaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Marcelo B SzteinCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
IMMUNE MECHANISMS OF PROTECTION IN S TYPHI VACCINESR01AI036525 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Marcelo B. Sztein · 1994 to 2026
$12.2M
Systems Biology and Biostatistics CoreU19AI181108 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Rosangela Mezghanni · 2024 to 2026
$8.0M
NCI NIH HHS P30 CA134274NIAID NIH HHS R01 AI036525NIAID NIH HHS U19 AI181108
6 · The paper itself

Abstract

Introduction: T cell mediated immunity (T-CMI) is an important component of effective host immunity against intracellular pathogens such as Methods: Here, peripheral blood mononuclear cells from eighteen healthy volunteers with no history of typhoid fever vaccination or infection were co-cultured with autologous B-lymphoblastoid cell lines (B-LCL) previously infected with wt ST as antigen presenting cells. Non-infected B-LCL (NI) were used as controls. After 18 h or 40 h of stimulation, cells were stained with a 52-parameter mass cytometry antibody panel and analyzed using manual gating, dimensionality reduction and unsupervised clustering approaches. We studied conventional CD4 Results: All studied cell subsets showed significant (p<0.01) baseline responsiveness to ST-infected target cells when compared to NI target cells. Most functional responses were observed in activation, homing, and cytotoxicity markers across all conventional and non-conventional T cell subsets, defining in great depth the characteristics of baseline T-CMI to S. Typhi. Discussion: This high-dimensional approach showed a complex interaction between distinct cell subsets with multifunctional properties and extended previous insights into the baseline T-CMI to

Indexed as

Immunity, CellularSalmonella typhiT-LymphocytesTyphoid FeverAdultFemaleHealthy VolunteersHumansMaleMiddle AgedT-Lymphocyte SubsetsYoung Adultbaseline immunityhigh dimensional data analysismass cytometrymultifunctional responsesSalmonella enterica serovar TyphiS. TyphiT cell-mediated immunity

Identifiers

PMID42889155
PMCPMC13669112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.